MedTrace Logo

IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma

NCT00294476 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2006-10-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of IVIG in the treatment of metastatic cancer of the prostate, colon and melanoma.

Conditions

  • Cancer of Colon
  • Malignant Melanoma
  • Urologic Cancer

Interventions

DRUG

IVIG

PROCEDURE

Biological Therapy

Sponsors & Collaborators

  • GammaCan

    lead INDUSTRY

Principal Investigators

  • Dan Aderka, M.D. · Oncology institute, Sheba Madical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00294476 on ClinicalTrials.gov